Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayer B Davidson

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
Journal of Diabetes|March 2, 2019
Delayed response to an injection of U-500 regular insulin is not rareMayer B Davidson
Diabetes Care|May 24, 2014
Insulin analogs--is there a compelling case to use them? No!Mayer B Davidson
Diabetes, Obesity & Metabolism|August 29, 2024
Glycaemic treatment of newly diagnosed type 2 diabetesMayer B Davidson
Annals of Internal Medicine|September 30, 2024
In adults with hypertension and high CV risk, intensive vs. standard BP-lowering therapy reduced major vascular eventsMayer B Davidson
Diabetes Care|July 29, 2003
Effect of nurse-directed diabetes care in a minority populationMayer B Davidson
Diabetes Care|July 30, 2010
Counterpoint: postprandial glucose levels are not a clinically important treatment targetMayer B Davidson
Diabetes Research and Clinical Practice|May 31, 2020
The "Cost-Effective" beneficial effect of pioglitazone on cardiovascular diseaseMayer B Davidson
Diabetes Care|June 29, 2004
Twice-Daily NPH or mixture insulins versus triple therapy: apples versus oranges: response to Poulsen et alMayer B Davidson
Annals of Internal Medicine|February 3, 2005
Glycemia and risk for cardiovascular diseaseMayer B Davidson
Diabetes|April 28, 2004
Status of research funding by the American Diabetes Association--5th and final yearMayer B Davidson
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
Journal of Diabetes|March 2, 2019
Delayed response to an injection of U-500 regular insulin is not rareMayer B Davidson
Diabetes Care|May 24, 2014
Insulin analogs--is there a compelling case to use them? No!Mayer B Davidson
Diabetes, Obesity & Metabolism|August 29, 2024
Glycaemic treatment of newly diagnosed type 2 diabetesMayer B Davidson
Annals of Internal Medicine|September 30, 2024
In adults with hypertension and high CV risk, intensive vs. standard BP-lowering therapy reduced major vascular eventsMayer B Davidson
Diabetes Care|July 29, 2003
Effect of nurse-directed diabetes care in a minority populationMayer B Davidson
Diabetes Care|July 30, 2010
Counterpoint: postprandial glucose levels are not a clinically important treatment targetMayer B Davidson
Diabetes Research and Clinical Practice|May 31, 2020
The "Cost-Effective" beneficial effect of pioglitazone on cardiovascular diseaseMayer B Davidson
Diabetes Care|June 29, 2004
Twice-Daily NPH or mixture insulins versus triple therapy: apples versus oranges: response to Poulsen et alMayer B Davidson
Annals of Internal Medicine|February 3, 2005
Glycemia and risk for cardiovascular diseaseMayer B Davidson
Diabetes|April 28, 2004
Status of research funding by the American Diabetes Association--5th and final yearMayer B Davidson
Pageof 15